1
|
Moussa Z, Perez Paz A, Khalaf MA, Judeh ZMA, Alzamly A, Samadi A, Al-Fahemi JH, Tatina MB, Al-Masri HT, Jassas RS, Ahmed SA. First Exclusive Stereo- and Regioselective Preparation of 5-Arylimino-1,3,4-Selenadiazole Derivatives: Synthesis, NMR analysis, and Computational Studies. Chem Asian J 2023; 18:e202300475. [PMID: 37495559 DOI: 10.1002/asia.202300475] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2023] [Revised: 07/14/2023] [Accepted: 07/24/2023] [Indexed: 07/28/2023]
Abstract
Isoselenocyanates are valuable coupling partners required for preparing key chemical intermediates and biologically active molecules in an accelerated and effective way. Likewise, (Z)-2-oxo-N-phenylpropanehydrazonoyl chlorides have been employed in numerous one-step heteroannulation reactions to assemble the structural core of several various kinds of heterocyclic compounds. Here, we describe the inverse electron demand 1,3-dipolar cycloaddition reaction of isoselenocyanates with a variety of substituted (Z)-2-oxo-N-phenylpropanehydrazonoyl chlorides to generate, regioselectively and stereoselectively, a series of 5-arylimino-1,3,4-selenadiazole derivatives comprising a multitude of functional groups on both aryl rings. The synthetic method features gentle room-temperature conditions, wide substrate scope, and good to high reaction yields. The selenadiazoles were separated by gravity filtration in all instances and chemical structures were validated by multinuclear NMR spectroscopy and high accuracy mass spectral measurements. First conclusive molecular structure elucidation of the observed 5-arylimino-selenadiazole regioisomer was verified by single-crystal X-ray diffraction analysis. Crystal-structure measurement was successfully carried out on (Z)-1-(4-(4-iodophenyl)-5-(p-tolylimino)-4,5-dihydro-1,3,4-selenadiazol-2-yl)ethan-1-one and (Z)-1-(5-((4-methoxyphenyl)imino)-4-(4-(methylthio)phenyl)-4,5-dihydro-1,3,4-selenadiazol-2-yl)ethan-1-one. Likewise, the (Z)-geometry of the hydrazonoyl chloride reactant was proven by X-ray diffraction studies. As representative examples, crystal-structure determination was carried out on (Z)-2-oxo-N-phenylpropanehydrazonoyl chloride and (Z)-N-(3,5-bis(trifluoromethyl)phenyl)-2-oxopropanehydrazonoyl chloride. Density functional theory calculations at the B3LYP-D4/def2-TZVP level were conducted to support the noted experimental findings and suggested mechanism.
Collapse
Affiliation(s)
- Ziad Moussa
- Department of Chemistry, College of Science, United Arab Emirates University, P. O. Box 15551, Al Ain, United Arab Emirates
| | - Alejandro Perez Paz
- Department of Chemistry, College of Science, United Arab Emirates University, P. O. Box 15551, Al Ain, United Arab Emirates
| | - Mohamed A Khalaf
- Department of Chemistry, College of Science, United Arab Emirates University, P. O. Box 15551, Al Ain, United Arab Emirates
| | - Zaher M A Judeh
- School of Chemical and Biomedical Engineering, Nanyang Technological University, 62 Nanyang Drive, N1.2-B1-14, Singapore, 637459, Singapore
| | - Ahmed Alzamly
- Department of Chemistry, College of Science, United Arab Emirates University, P. O. Box 15551, Al Ain, United Arab Emirates
| | - Abdelouahid Samadi
- Department of Chemistry, College of Science, United Arab Emirates University, P. O. Box 15551, Al Ain, United Arab Emirates
| | - Jabir H Al-Fahemi
- Department of Chemistry, Faculty of Applied Sciences, Umm Al-Qura University, Makkah, 21955, Saudi Arabia
| | - Madhu Babu Tatina
- Division of Organic Synthesis & Process Chemistry, CSIR-Indian Institute of Chemical Technology (CSIR-IICT), Hyderabad, Telangana, 500007, India
| | - Harbi Tomah Al-Masri
- Department of Chemistry, Faculty of Sciences, Al al-Bayt University, P. O. Box 130040, Mafraq, 25113, Jordan
| | - Rabab S Jassas
- Department of Chemistry, Jamoum University College, Umm Al-Qura University, 21955, Makkah, Saudi Arabia
| | - Saleh A Ahmed
- Department of Chemistry, Faculty of Applied Sciences, Umm Al-Qura University, Makkah, 21955, Saudi Arabia
- Department of Chemistry, Faculty of Science, Assiut University, 71516, Assiut, Egypt
| |
Collapse
|
2
|
Wu J, Wang Z, Wang C, Wang Y, Li H, Luo H, Li H, Wang F, Li D, Yang J. Research Progress on the Synthesis of Nitrogen-Containing Compounds with Cyanamide as a Building Block. CHINESE J ORG CHEM 2023. [DOI: 10.6023/cjoc202208020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/02/2023]
|
3
|
Wei Z, Zhang Q, Tang M, Zhang S, Zhang Q. Diversity-Oriented Synthesis of 1,2,4-Triazols, 1,3,4-Thiadiazols, and 1,3,4-Selenadiazoles from N-Tosylhydrazones. Org Lett 2021; 23:4436-4440. [PMID: 33988376 DOI: 10.1021/acs.orglett.1c01379] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
The diversity-oriented synthesis of 1,2,4-triazols, 1,3,4-thiadiazols, and 1,3,4-selenadiazoles from N-tosylhydrazones was developed, and the reactions were general for a wide range of substrates, in which NH2CN, KOCN, KSCN, and KSeCN were used as odorless sources. Two different pathways were proposed, and N-tosylhydrazonoyl chlorides were formed in situ in the presence of NCS.
Collapse
Affiliation(s)
- Zeyang Wei
- School of Pharmacy, Lanzhou University, Lanzhou 730000, P. R. China
| | - Qi Zhang
- School of Pharmacy, Lanzhou University, Lanzhou 730000, P. R. China
| | - Meng Tang
- School of Pharmacy, Lanzhou University, Lanzhou 730000, P. R. China
| | - Siyu Zhang
- School of Pharmacy, Lanzhou University, Lanzhou 730000, P. R. China
| | - Qian Zhang
- School of Pharmacy, Lanzhou University, Lanzhou 730000, P. R. China
| |
Collapse
|
4
|
Chen Z, Li D, Xu N, Fang J, Yu Y, Hou W, Ruan H, Zhu P, Ma R, Lu S, Cao D, Wu R, Ni M, Zhang W, Su W, Ruan BH. Novel 1,3,4-Selenadiazole-Containing Kidney-Type Glutaminase Inhibitors Showed Improved Cellular Uptake and Antitumor Activity. J Med Chem 2018; 62:589-603. [PMID: 30543285 DOI: 10.1021/acs.jmedchem.8b01198] [Citation(s) in RCA: 56] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
Kidney-type glutaminase [KGA/isoenzyme glutaminase C (GAC)] is becoming an important tumor metabolism target in cancer chemotherapy. Its allosteric inhibitor, CB839, showed early promise in cancer therapeutics but limited efficacy in in vivo cancer models. To improve the in vivo activity, we explored a bioisostere replacement of the sulfur atom in bis-2-(5-phenylacetamido-1,2,4-thiadiazol)ethyl sulfide and CB839 analogues with selenium using a novel synthesis of the selenadiazole moiety from carboxylic acids or nitriles. The resulting selenadiazole compounds showed enhanced KGA inhibition, more potent induction of reactive oxygen species, improved inhibition of cancer cells, and higher cellular and tumor accumulation than the corresponding sulfur-containing molecules. However, both CB839 and its selenium analogues show incomplete inhibition of the tested cancer cells, and a partial reduction in tumor size was observed in both the glutamine-dependent HCT116 and aggressive H22 liver cancer xenograft models. Despite this, tumor tissue damage and prolonged survival were observed in animals treated with the selenium analogue of CB839.
Collapse
Affiliation(s)
- Zhao Chen
- College of Pharmaceutical Science, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, IDD & CB , Zhejiang University of Technology , Hangzhou 310014 , China
| | - Di Li
- College of Pharmaceutical Science, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, IDD & CB , Zhejiang University of Technology , Hangzhou 310014 , China
| | - Ning Xu
- College of Pharmaceutical Science, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, IDD & CB , Zhejiang University of Technology , Hangzhou 310014 , China
| | - Jinzhang Fang
- College of Pharmaceutical Science, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, IDD & CB , Zhejiang University of Technology , Hangzhou 310014 , China
| | - Yan Yu
- College of Pharmaceutical Science, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, IDD & CB , Zhejiang University of Technology , Hangzhou 310014 , China
| | - Wei Hou
- College of Pharmaceutical Science, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, IDD & CB , Zhejiang University of Technology , Hangzhou 310014 , China
| | - Haoqiang Ruan
- College of Pharmaceutical Science, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, IDD & CB , Zhejiang University of Technology , Hangzhou 310014 , China
| | - Panpan Zhu
- College of Pharmaceutical Science, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, IDD & CB , Zhejiang University of Technology , Hangzhou 310014 , China
| | - Renchao Ma
- College of Pharmaceutical Science, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, IDD & CB , Zhejiang University of Technology , Hangzhou 310014 , China
| | - Shiying Lu
- College of Pharmaceutical Science, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, IDD & CB , Zhejiang University of Technology , Hangzhou 310014 , China
| | - Danhui Cao
- College of Pharmaceutical Science, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, IDD & CB , Zhejiang University of Technology , Hangzhou 310014 , China
| | - Rui Wu
- College of Pharmaceutical Science, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, IDD & CB , Zhejiang University of Technology , Hangzhou 310014 , China
| | - Mowei Ni
- Center for Cancer Research , Zhejiang Cancer Hospital , Hangzhou 310022 , China
| | - Wei Zhang
- Department of Urology , Tongde Hospital of Zhejiang Province , Hangzhou 310012 , China
| | - Weike Su
- College of Pharmaceutical Science, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, IDD & CB , Zhejiang University of Technology , Hangzhou 310014 , China
| | - Benfang Helen Ruan
- College of Pharmaceutical Science, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, IDD & CB , Zhejiang University of Technology , Hangzhou 310014 , China
| |
Collapse
|